by Richard Daverman, PhDChinaBio TodayChina biopharma stocks listed on US exchanges weathered a difficult first quarter of 2008. The ChinaBio Stock Index fell from 1675 to 1215 during the three months, a substantial decline of 27.4%. During the same time, the Dow Jones Industrials Average was lower by just 7.5%, though Nasdaq lived up to its reputation for volatility by dropping 14%. Still, the loss in the ChinaBio Index was almost twice as much. China, on the other hand, suffere[...]
Read More...
[Source: The Money Blogs]
No comments:
Post a Comment